Paroxetine vs Pembrolizumab

## Paroxetine vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Paroxetine** and **Pembrolizumab**.

## Mechanism of Action

**Paroxetine**: Potent selective serotonin reuptake inhibitor with additional muscarinic and NE reuptake inhibition.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Paroxetine — 21 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Paroxetine — C19H20FNO3; Pembrolizumab — N/A.

**Molecular Weight**: Paroxetine — 329.3730 g/mol; Pembrolizumab — N/A.

**Type**: Paroxetine — Small molecule; Pembrolizumab — Antibody.